{"disease":{"id":"dermatology-and-oncology","name":"dermatology and oncology"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04760080","title":"Association of Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic Melanoma : a Retrospective Case-control Study.","phase":"","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}